How Toll-like receptors and Nod-like receptors contribute to innate immunity in mammals

Journal of Endotoxin Research

Volumn 11, Issue 6, 2005, Pages 390-394

  Fritz, Jörg H ^a   Girardin, Stephen E ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Innate immunity; Nod like receptors; Toll like receptors

Indexed keywords

CARRIER PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CELL PROTEIN; NOD LIKE RECEPTOR; PROTEIN NOD1; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ARTICLE; CELL COMMUNICATION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; HOST RESISTANCE; INNATE IMMUNITY; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; HUMANS; IMMUNITY, NATURAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAMMALS; MICE; NOD1 SIGNALING ADAPTOR PROTEIN; NOD2 SIGNALING ADAPTOR PROTEIN; RECEPTORS, G-PROTEIN-COUPLED; TOLL-LIKE RECEPTORS;

MAMMALIA;

EID: 28444459897     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805105X76850     Document Type: Article

References (45)

1. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 1996; 272: 50-53.
2. Girardin SE, Philpott DJ, Lemaitre B. Sensing microbes by diverse hosts. EMBO Report 2003; 4: 932-936.
3. Lemaitre B. The road to Toll. Nat Rev Immunol 2004; 4: 521-527.
4. Akira S. Mammalian Toll-like receptors. Curr Opin Immunol 2003; 15: 5-11.
5. Carneiro LA, Travassos LH, Philpott DJ. Innate immune recognition of microbes through Nod1 and Nod2: implications for disease. Microbes Infect 2004; 6: 609-616.
6. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511.
7. Lien E, Golenbock DT. Adjuvants and their signaling pathways: beyond TLRs. Nat Immunol 2003; 4: 1162-1164.
8. Hayashi F, Smith KD, Ozinsky A et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001; 410: 1099-1103.
9. Hemmi H, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740-745.
10. Zhang D, Zhang MS, Hayden MS et al. A Toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004; 303: 1522-1526.
11. Underhill DM. Toll-like receptors: networking for success. Eur J Immunol 2003; 33: 1767-1775.
12. Ozinsky A, Underhill JD, Fontenot JD et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Natl Acad Sci USA 2000; 97: 13766-13771.
13. Morr M, Takeuchi O, Akira S, Simon MM, Muhlradt PF et al. Differential recognition of structural details of bacterial lipopeptides by Toll-like receptors. Eur J Immunol 2002; 32: 3337-3347.
14. Takeuchi O, Sato S, Horiuchi T et al. Role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 2002; 169: 10-14.
15. Travassos LH, Girardin SE, Philpott DJ et al. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Report 2004; 5: 1000-1006.
16. Kaisho T, Akira S. Pleiotropic function of Toll-like receptors. Microbes Infect 2004; 6: 1388-1394.
17. Edelson BT, Unanue ER. MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity. J Immunol 2002; 169: 3869-3875.
18. Haziot A, Hijiya N, Gangloff SC, Silver J, Goyert SM. Induction of a novel mechanism of accelerated bacterial clearance by lipopolysaccharide in CD14-deficient and Toll-like receptor 4-deficient mice. J Immunol 2001; 166: 1075-1078.
19. Latz E et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004; 5: 190-198.
20. Hornef MW, Normark BH, Vandewalle A, Normark S. Intracellular recognition of lipopolysaccharide by Toll-like receptor 4 in intestinal epithelial cells. J Exp Med 2003; 198: 1225-1235.
21. Cossart P, Sansonetti PJ. Bacterial invasion: the paradigms of entero-invasive pathogens. Science 2004; 304: 242-248.
22. Hornef MW, Wick MJ, Rhen M, Normark S. Bacterial strategies for overcoming host innate and adaptive immune responses. Nat Immunol 2002; 3: 1033-1040.
23. Girardin SE, Tournebize R, Mavris M et al. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Report 2001; 2: 736-742.
24. Ting JP, Davis BK. CATERPILLER: a novel gene family important in immunity, cell death, and diseases. Annu Rev Immunol 2005; 23: 387-414.
25. Girardin SE, Travassos LH, Herve M et al. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem 2003.
26. Girardin SE, Philpott DJ. The role of peptidoglycan recognition in innate immunity. Eur J Immunol 2004; 34: 1777-1782.
27. Boneca IG. The role of peptidoglycan in pathogenesis. Curr Opin Microbiol 2005; 8: 46-53.
28. Girardin SE, Boneca IG, Carneiro LA et al. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 2003; 300: 1584-1587.
29. Chamaillard M, Hashimoto, Horie Y et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 2003; 4: 702-707.
30. Hugot JP, Chamaillard M, Zouali H et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
31. Ogura Y, Bonen DK, Inohara N et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-606.
32. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003; 3: 521-533.
33. Chamaillard M, Philpott D, Girardin SE et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci USA 2003; 100: 3455-3460.
34. Ogura Y, Saab L, Chen FF et al. Genetic variation and activity of mouse Nod2, a susceptibility gene for Crohn's disease small star, filled. Genomics 2003; 81: 369-377.
35. Kobayashi KS, Chamaillard M, Ogura Y et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005; 307: 731-734.
36. Maeda S, Hsu LC, Liu H et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 2005; 307: 734-738.
37. Ayabe T, Ashida T, Kohgo Y, Kono T. The role of Paneth cells and their antimicrobial peptides in innate host defense. Trends Microbiol 2004; 12: 394-398.
38. Li J, Moran T, Swanson E et al. Regulation of IL-8 and IL-1β expression in Crohn's disease associated NOD2/CARD15 mutations. Hum Mol Genet 2004.
39. Netea MG, Kullberg BJ, De Jong DJ et al. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease. Eur J Immunol 2004; 34: 2052-2059.
40. Adam A, Petit JF, Lrfrancier P, Lederer E. Muramyl peptides. Chemical structure, biological activity and mechanism of action. Mol Cell Biochem 1981; 41: 27-47.
41. Takada H, Yokoyama S, Yang S. Enhancement of endotoxin activity by muramyldipeptide. J Endotoxin Res 2002; 8: 337-342.
42. Chen CM et al. Reciprocal cross-talk between Nod2 and TAK1 signaling pathways. J Biol Chem 2004; 279: 25876-25882.
43. Traub S, Kubasch N, Morath S et al. Structural requirements of synthetic muropeptides to synergize with lipopolysaccharide in cytokine induction. J Biol Chem 2004; 279: 8694-8700.
44. Fritz JH, Girardin SE, Fitting C et al. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2- activating agonists. Eur J Immunol 2005; 35: 2459-2470.
45. Watanabe T, Kitani A, Murray PJ, Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004; 5: 800-808